Opportunity Information: Apply for PAR 09 246
Apply for PAR 09 246
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NIMH Career Transition Award for Intramural Investigators (K22)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.281 Mental Health Research Career/Scientist Development Awards 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Jul 31, 2009 and posted on Jul 31, 2009.
- Applicants must submit their applications by Sep 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIMH Career Transition Award for Intramural Investigators (K22) is a National Institute of Mental Health program designed to help established NIMH intramural scientists move from the NIMH Division of Intramural Research Programs (DIRP) into research positions in the extramural community, most commonly at domestic academic institutions. The core idea is to provide a structured bridge for investigators who already have a strong record of high-quality, mental health-relevant research and who are ready to take the next step into an externally based faculty or equivalent research appointment. In practical terms, it is meant to reduce the career and funding disruption that can happen when a federal intramural investigator transitions to an outside institution, while also positioning that investigator to launch an independent, sustainable extramural research program.
This opportunity uses the NIH Career Transition (K22) grant mechanism and is organized around a two-phase process. The first phase is an application prepared and submitted while the candidate is still in a tenured or tenure-track position within NIMH intramural laboratories. Phase 1 is the portion that undergoes peer review for scientific merit, and that review outcome is the main factor determining whether NIMH intends to support the candidate. Importantly, while Phase 1 is reviewed, the actual award is not made at that point. Instead, a strong Phase 1 review results in a written indication of NIMH commitment to make an award contingent on the successful completion of the transition requirements.
After a fundable Phase 1 score, the candidate is given up to 18 months to find and secure an appropriate extramural research position at a domestic academic institution and to negotiate a startup package. Once those negotiations are completed and the position is lined up, the candidate submits the Phase 2 application. Phase 2 is the application that is actually awarded, and it activates the K22 support at the new extramural institution. The K22 provides up to three years of support timed to the transition, functioning as a launch pad for the investigator to establish an independent program in their new setting.
Administratively, this is a discretionary grant funding opportunity issued by the National Institutes of Health, with the FOA identifier PAR-09-246 and the title "NIMH Career Transition Award for Intramural Investigators (K22)." It was originally posted on July 31, 2009, and the last listed closing date was September 7, 2012, with an archive date of October 8, 2012, indicating it is not a current open competition under that specific announcement. It falls under NIH activity categories tied to education and health, and it is associated with CFDA numbers including 93.281 (Mental Health Research Career/Scientist Development Awards), as well as 93.855 and 93.856 (areas related to immunology/transplantation and microbiology/infectious diseases), reflecting the broader NIH cataloging and potential intersections with mental health research rather than limiting the program strictly to one narrow scientific domain.
Eligibility, as listed in the announcement metadata, includes a wide set of institution types that can serve as applicant organizations for the extramural phase. These include public and state-controlled institutions of higher education, private institutions of higher education, certain nonprofit organizations (including 501(c)(3) nonprofits and some non-501(c)(3) nonprofits other than institutions of higher education), and for-profit organizations other than small businesses. The eligibility listing also explicitly includes institutions serving specific populations, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian Serving Institutions. Cost sharing or matching is not required, which matters because it reduces institutional financial barriers and keeps the focus on the candidate's merit, research plan, and the transition environment.
Overall, the K22 described here is best understood as a targeted transition mechanism for NIMH intramural investigators who have already demonstrated research excellence and are ready to move into the extramural ecosystem. It relies on rigorous peer review at Phase 1 to establish scientific credibility, then uses Phase 2 to formalize the move to an outside institution once the investigator has secured an appropriate position and startup support, with up to three years of K22 funding intended to stabilize and accelerate the investigator's independent research trajectory during that critical transition period.
Frequently Asked Questions (FAQs): NIMH Career Transition Award for Intramural Investigators (K22) - PAR-09-246
What is the NIMH Career Transition Award for Intramural Investigators (K22)?
The NIMH Career Transition Award for Intramural Investigators (K22) is an NIH/NIMH program intended to help established NIMH intramural scientists transition from the NIMH Division of Intramural Research Programs (DIRP) into research positions in the extramural community, most commonly at domestic academic institutions. It is designed to reduce career and funding disruption during the move and to support the launch of an independent, sustainable extramural research program.
Who is this K22 designed for?
This opportunity is described as being for established NIMH intramural scientists who already have a strong track record of high-quality, mental health-relevant research and who are ready to move from NIMH intramural laboratories into an externally based faculty or equivalent research appointment.
What is the overall purpose of the program?
The program is meant to provide a structured bridge from an NIMH intramural position to an extramural research position. The intent is to (1) minimize disruption that can occur when leaving a federal intramural environment and (2) position the investigator to quickly establish an independent extramural research program.
What grant mechanism does this opportunity use?
It uses the NIH Career Transition (K22) grant mechanism.
How is the K22 structured (Phase 1 vs Phase 2)?
The opportunity is organized as a two-phase process:
- Phase 1: Prepared and submitted while the candidate is still in a tenured or tenure-track position within NIMH intramural laboratories. Phase 1 is the portion that undergoes peer review for scientific merit.
- Phase 2: Submitted after the candidate has secured an appropriate extramural position and negotiated a startup package. Phase 2 is the application that is actually awarded and activates the K22 support at the new extramural institution.
When is Phase 1 submitted?
Phase 1 is submitted while the candidate is still employed in a tenured or tenure-track role within NIMH intramural laboratories (DIRP).
Which phase is peer reviewed?
Phase 1 undergoes peer review for scientific merit, and the review outcome is the main factor in determining whether NIMH intends to support the candidate.
Does a strong Phase 1 score mean the award is made immediately?
No. Even with a strong (fundable) Phase 1 review, the award is not made at that point. Instead, a strong Phase 1 outcome leads to a written indication of NIMH commitment to make an award, contingent upon successfully completing the transition requirements.
What happens after a fundable Phase 1 score?
After a fundable Phase 1 score, the candidate has up to 18 months to find and secure an appropriate extramural research position at a domestic academic institution and to negotiate a startup package. Once those steps are completed, the candidate submits the Phase 2 application.
How long does the candidate have to complete the transition?
The candidate is given up to 18 months after a fundable Phase 1 score to secure an extramural position and complete startup negotiations, before submitting Phase 2.
What is the role of the extramural institution in Phase 2?
Phase 2 is submitted once an extramural research position is lined up and a startup package has been negotiated. The K22 support is then activated at the new extramural institution through the Phase 2 award.
How much support does the K22 provide, and for how long?
The K22 provides up to three years of support, timed to the investigator’s transition and intended to serve as a launch pad for establishing an independent research program in the new extramural setting.
Where is the investigator expected to move for the extramural phase?
The program is described as supporting a move into the extramural community, most commonly at domestic academic institutions. The Phase 2 transition described here centers on securing an extramural position at a domestic academic institution.
Is this a current, open funding opportunity?
Based on the information provided, this specific announcement (FOA identifier PAR-09-246) is archived and not a current open competition under that announcement. It was originally posted on July 31, 2009, with the last listed closing date of September 7, 2012, and an archive date of October 8, 2012.
What is the FOA identifier and title for this opportunity?
The FOA identifier is PAR-09-246, and the title is "NIMH Career Transition Award for Intramural Investigators (K22)."
Which agency and institute issue this opportunity?
It is a discretionary grant funding opportunity issued by the National Institutes of Health (NIH), specifically through the National Institute of Mental Health (NIMH).
What kinds of organizations can serve as applicant institutions for the extramural phase?
The eligibility metadata lists a broad range of institution types that can serve as applicant organizations for the extramural phase, including:
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofit organizations, including 501(c)(3) nonprofits and certain non-501(c)(3) nonprofits other than institutions of higher education
- For-profit organizations other than small businesses
Are minority-serving institutions included as eligible applicants?
Yes. The eligibility listing explicitly includes institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian Serving Institutions.
Is cost sharing or matching required?
No. Cost sharing or matching is not required for this opportunity.
What kinds of research areas are associated with this opportunity?
The program is described as supporting investigators with high-quality, mental health-relevant research. The opportunity is also associated with CFDA numbers including 93.281 (Mental Health Research Career/Scientist Development Awards) as well as 93.855 and 93.856 (areas related to immunology/transplantation and microbiology/infectious diseases). This suggests broader NIH cataloging and potential intersections with mental health research, rather than restricting the program to a single narrow scientific domain.
What is the NIMH DIRP, and why does it matter for eligibility?
The NIMH Division of Intramural Research Programs (DIRP) is the intramural (inside NIH) research environment the candidate is transitioning from. Phase 1 is specifically prepared and submitted while the candidate is still in a tenured or tenure-track position within NIMH intramural laboratories, making DIRP status central to the described candidate pathway.
What is the main benefit of this K22 during a transition?
The core benefit described is stability during a high-risk career move: the K22 is intended to reduce disruption when transitioning out of the federal intramural setting and to provide up to three years of support to accelerate the investigator’s independent extramural research trajectory in the new institution.
What triggers the start of K22 funding at the new institution?
K22 funding is activated through the Phase 2 application, after the candidate has secured an extramural position and negotiated a startup package. Phase 2 is the portion that is actually awarded.
Browse more opportunities from the same category: Education Health
Next opportunity: Air Quality Health Effects and Highway Proximity
Previous opportunity: Partnerships for Development of Therapeutics and Diagnostics for Drug Resistant Bacteria and Eukaryotic Parasites (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 09 246
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 09 246) also looked into and applied for these:
| Funding Opportunity |
|---|
| Innovations in Biomedical Computational Science and Technology Initiative (SBIR R43/R44) Apply for PAR 09 220 Funding Number: PAR 09 220 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovations in Biomedical Computational Science and Technology Initiative (STTR R41/R42) Apply for PAR 09 221 Funding Number: PAR 09 221 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Optimization of Small Molecule Probes for the Nervous System (R21) Apply for PAR 09 251 Funding Number: PAR 09 251 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Image guided Drug Delivery in Cancer (R01) Apply for PA 09 253 Funding Number: PA 09 253 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Biology of Estrogen Receptor Negative Breast Cancer in Various Racial and Ethnic Groups (U01) Apply for RFA CA 09 026 Funding Number: RFA CA 09 026 Agency: National Institutes of Health Category: Education Health Funding Amount: $667,000 |
| Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R01) Apply for PA 09 243 Funding Number: PA 09 243 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R21) Apply for PA 09 244 Funding Number: PA 09 244 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Optimization of Small Molecule Probes for the Nervous System (STTR R41) Apply for PAR 09 259 Funding Number: PAR 09 259 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Optimization of Small Molecule Probes for the Nervous System (SBIR R43) Apply for PAR 09 260 Funding Number: PAR 09 260 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 09 019 Funding Number: RFA RM 09 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition for Research Centers in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR) U54 Apply for PAR 09 261 Funding Number: PAR 09 261 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploring Epigenomic Processes and Non Coding RNAs in HIV/AIDS (R01) Apply for RFA DA 10 010 Funding Number: RFA DA 10 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Exploring Epigenomic Processes and Non Coding RNAs in HIV/AIDS (R21) Apply for RFA DA 10 011 Funding Number: RFA DA 10 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Targeted Library Synthesis and Screening at Novel Targets for Potential Drug Addiction Treatments and Research Tools (R21/R33) Apply for RFA DA 10 005 Funding Number: RFA DA 10 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) (R01) Apply for RFA GM 10 009 Funding Number: RFA GM 10 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Developing Research Capacity in Africa for Studies on HIV Associated Malignancies (D43) Apply for RFA CA 09 016 Funding Number: RFA CA 09 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Medications Development for Cannabis Related Disorders (R01) Apply for RFA DA 10 016 Funding Number: RFA DA 10 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011 and 2012 (P50) Apply for PAR 10 003 Funding Number: PAR 10 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R21) Apply for PAR 10 002 Funding Number: PAR 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Discovery for Nervous System Disorders (R01) Apply for PAR 10 001 Funding Number: PAR 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 246", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.